Feb 10
PTCL Research Updates
Posted by T-Cell Leukemia Lymphoma Foundation
We are excited to launch a monthly series dedicated to recent research updates on T-cell lymphomas and leukemias. The selected articles below were chosen from prominent publications from around the world.
*Please note that a journal subscription may be required to view full articles*
Haematologica. 2016 Jan 27. pii: haematol.2015.139253. [Epub ahead of print]
Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.
Yoo HY1, Kim P2, Kim WS3, Lee SH1, Kim S2, Kang SY4, Jang HY2, Lee JE5, Kim J2, Kim SJ3, Ko YH6, Lee S7.
http://www.ncbi.nlm.nih.gov/pubmed/26819049
Crit Rev Oncol Hematol. 2016 Jan 3. pii: S1040-8428(15)30106-2. doi: 10.1016/j.critrevonc.2015.12.016. [Epub ahead of print]
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas.
Zinzani PL1, Bonthapally V2, Huebner D3, Lutes R3, Chi A4, Pileri S5.
http://www.ncbi.nlm.nih.gov/pubmed/26811013
Crit Rev Oncol Hematol. 2016 Jan 2. pii: S1040-8428(15)30107-4. doi: 10.1016/j.critrevonc.2015.12.018. [Epub ahead of print]
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas.
Zinzani PL1, Bonthapally V2, Huebner D3, Lutes R3, Chi A4, Pileri S5.
http://www.ncbi.nlm.nih.gov/pubmed/26811014
J Clin Oncol. 2016 Jan 25. pii: JCO635540. [Epub ahead of print]
Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.
Adams SV1, Newcomb PA1, Shustov AR2.
http://www.ncbi.nlm.nih.gov/pubmed/26811530
Blood. 2016 Jan 26. pii: blood-2015-11-685032. [Epub ahead of print]
Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia.
http://www.ncbi.nlm.nih.gov/pubmed/26813676